V. Tahan Et Al. , "Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis," 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , vol.42, Paris, France, pp.254-255, 2005
Tahan, V. Et Al. 2005. Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis. 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , (Paris, France), 254-255.
Tahan, V., Imeryuz, N., Uzun, H., EREN, F., Gogas, D., Barghi, I., ... Celikel, C.(2005). Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis . 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (pp.254-255). Paris, France
Tahan, V Et Al. "Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis," 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 2005
Tahan, V Et Al. "Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis." 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Paris, France, pp.254-255, 2005
Tahan, V. Et Al. (2005) . "Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis." 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Paris, France, pp.254-255.
@conferencepaper{conferencepaper, author={V Tahan Et Al. }, title={Rosiglitazone shows an anti-inflammatory effect by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis}, congress name={40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver}, city={Paris}, country={France}, year={2005}, pages={254-255} }